A02BC04 • rabeprazole • Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Proton pump inhibitors
Rabeprazole is a proton pump inhibitor used for the treatment of gastroesophageal reflux disease (GERD), gastric ulcers, and other conditions associated with excessive gastric acid secretion. It works by reducing gastric acid production, alleviating symptoms, and promoting healing of the gastric mucosa.
The medication is taken orally, as directed by a doctor, usually once daily before a meal. It is important for patients to follow the treatment regimen and inform the doctor about any other medications being used.
Patients should be aware of potential side effects, such as headaches, nausea, or diarrhea. It is important to inform the doctor of any unusual symptoms.
Common side effects include headaches, nausea, and diarrhea. In rare cases, severe reactions such as allergic reactions or hypomagnesemia may occur. Patients should be informed of these risks before use.
Substance: rabeprazole
Date of last drug list: 01-07-2013
Commercial code: W59110003
Concentration: 20mg
Pharmaceutical form: gastro-resistant tablets
Quantity: 28
Product type: generic
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.